William T. Abraham, M.D., F.A.C.P., F.A.C.C.

Dr. Abraham is a Professor of Internal Medicine and Chief of the Division of Cardiovascular Medicine at The Ohio State University College of Medicine. He also serves as Associate Director for Clinical and Translational Research at the Dorothy M. Davis Heart and Lung Research Institute. Dr. Abraham earned his medical degree from Harvard Medical School in Boston. He is board certified in Internal Medicine and in Cardiovascular Diseases.

Dr. Abraham's research interests include the role of the kidney in heart failure, neurohormonal mechanisms in heart failure, systemic and cardiac adrenergic activity in heart failure, and clinical drug and device trials in heart failure and cardiac transplantation.

Dr. Abraham serves on the editorial boards of several major journals including the Journal of Cardiac Failure, Congestive Heart Failure, and Journal Watch Cardiology. He is also a scientific reviewer for such publications as Circulation, the European Heart Journal, and the Journal of the American College of Cardiology.

Edward J. Benz, Jr., M.D.

Dr. Benz is President of the Dana-Farber Cancer Institute, CEO of Dana-Farber/Partners CancerCare, Director and Principal Investigator of the Dana-Farber/Harvard Cancer Center, and a member of the Governing Board of Dana-Farber/Children's Cancer Center. He is also the Richard and Susan Smith Professor of Medicine, Professor of Pediatrics, and Professor of Pathology at Harvard Medical School. Dr. Benz graduated from Harvard Medical School in 1973 and received his training at Brigham and Women's Hospital and the National Institutes of Health.

He is also a clinical hematologist and an active NIH-funded investigator. His research focuses on the molecular pathology and physiology of red cell development, the molecular basis of inherited hemolytic anemias, and the use of the red cell homeostatic system as a model to study gene regulation and growth control in other tissues. Dr Benz is also an associate editor of the New England Journal of Medicine.

Jeffrey Borer, M.D.

Dr. Borer is a Professor of Cardiovascular Medicine in Cardiothoracic Surgery, a Professor of Cardiovascular Medicine in Radiology, and The Gladys and Roland Harriman Professor of Cardiovascular Medicine at the Weill Cornell Medical College at Cornell University. Dr. Borer is also the Chair of the FDA’s Cardiovascular Renal Drugs Advisory Committee. His research interest aims to elucidate the pathophysiology of myocardial dysfunction and heart failure in non-ischemic mitral or aortic regurgitation. Dr. Borer received his medical degree from Cornell Medical College in 1969.

Douglas L. Mann, M.D.

Dr. Mann is a Professor of Medicine at Baylor College of Medicine and Director of the Winters Center for Heart Failure Research. He received his undergraduate training at Lafayette College and his medical degree from Temple University School of Medicine. After finishing his residency in Medicine at Temple University Hospital, he completed his Cardiology Fellowship at the University of California at San Diego, and was a Clinical and Research Follow at the Massachusetts General Hospital, and a Research Fellow in Cardiology at Temple University Hospital.

The major focus of Dr. Mann's laboratory research has been to define the basic cellular and molecular mechanism(s) that are responsible for disease progression in the failing heart. His research efforts have focused on translating novel findings obtained in the basic research laboratory into multi-center clinical trials.

Dr Mann is an associate editor for Circulation and Deputy Editor for Chest, and is a member of the Editorial Board of Journal of the American College of Cardiology, Cardiology Today and Heart and Vessels, Heart Failure Reviews and Heart Failure Monitor. He has received numerous awards including the Alfred Soffer Award for Editorial Excellence from the American College of Chest Physicians, the Michael E. Debakey Award for Excellence in Research.

Dr. Mann is a member of the American Society for Clinical Investigation and the Association of University Cardiologists. He is a Fellow of both the American College of Cardiology and the American College of Chest Physicians. He is also a member of the Executive Council for the Heart Failure Society of America.

Hani N. Sabbah, Ph.D., F.A.C.C., F.C.C.P., F.A.H.A.

Dr. Sabbah is a tenured Professor of Medicine at Case Western Reserve University in Cleveland and the Director of Cardiovascular Research at the Henry Ford Health System in Detroit. Laboratories directed by Dr. Sabbah include traditional biochemistry, molecular biology, cell electrophysiology, pathology and immunohistochemistry as well as organ and whole body physiology. He is the principal investigator on numerous research grants, awards and contracts from the National Institutes of Health, national and local health organizations as well as national and international industrial concerns.

Dr. Sabbah is a fellow of the American College of Cardiology, American College of Chest Physicians, and the American Heart Association. He has authored over 20 book chapters, 300 peer reviewed publications and 500 abstracts presented at national and international scientific conferences. He is member of numerous local, state, national and international executive and scientific committees on cardiovascular disease and heart failure. Dr. Sabbah is member of the editorial board of several peer-reviewed scientific journals and is the co Editor-in-Chief of the journal Heart Failure Reviews. He received his B.S. in Aerospace Engineering from the University of Oklahoma and a doctorate in Biomedical Sciences and Medical Physics from Oakland University.